TR / EN

PHARMA INDUSTRY STATISTICS AND KEY FIGURES

Number of Industry Supported Clinical Trials in Turkey
5211
Investment to Industry Supported Clinical Trials in Turkey
869 million TL1
Out of the 172 new molecules approved by EMA (European Medicines Agency) between 2015-2018, 31 are reimbursed in Turkey.2
Approximately 5% of new molecules marketed worldwide between 2017-2019 are available in Turkey.3
New molecules are approved in Turkey approximately with 3 to 4 years delay.3
In 2019, there were 474 ventures manufacturing basic pharmaceutical products and ingredients in Turkey, providing employment to 39,068 staff.4
17
Rank of Turkish pharmaceutical market in the world in 20193, 5
1/63
Ratio of the Turkish pharmaceutical market to USA market3, 5
41%
Share of USA in global pharmaceutical market5
51%
Share of AIFD members in Turkish pharmaceutical market6
29%
Share of innovative products in reimbursed pharmaceutical market6
19,4%
Nominal growth of the total pharmaceutical market in 20206
Yearly growth rate of the pharmaceutical market

Nominal growth of reimbursed pharma market in 2020
%18.26

Market Growth contributors:3
Volume -5.7 points
Product mix 11.1 points
Price increases 12.4 points
New Products 0.4 points

Ranking of Turkey in World
Pharmaceutical Market3, 5

Reimbursed Pharmaceutical Market
Volume and Value6